GENEMEDICS APP
GENEMEDICS NUTRITION
Potential Health Benefits
LGD-3033 benefits include maintaining bone strength and quality, enhancing sexual function, and improving muscle mass and strength. It may also help reduce the incidence of urinary tract infections.
- May help maintain bone strength and quality [1-10]
- May improve sexual function [11-18]
- May help improve muscle mass and strength [19-24]
- May decrease urinary tract infections [25-26]
Key Takeaways
- Selective Action: LGD-3033 selectively binds to androgen receptors, primarily targeting muscle and bone tissues, minimizing side effects on other organs.
- Muscle and Bone Benefits: It promotes increased muscle mass, enhances strength, and maintains bone density and quality.
- Sexual Function Improvement: LGD-3033 may improve sexual function by modulating androgen receptors involved in reproductive health.
- Reduced Urinary Issues: It may decrease the risk of urinary tract infections by supporting tissue integrity and immune response.
- Potential Therapeutic Use: LGD-3033 is being studied for its potential to treat conditions like osteoporosis and muscle-wasting disorders.
What is LGD-3033?
LGD-3033 is a drug that acts as a selective androgen receptor modulator (SARM). It was initially designed and developed to reduce the prevalence and cure muscle wasting associated with different medical conditions like cancer. Today, this supplement is used by athletes for building muscles and improving exercise endurance. LGD-3033 increases muscle mass by improving water retention. Interestingly, the benefits of this SARM are not limited to muscle mass growth. LGD-3033 has other health benefits and is known to have milder side effects than LGD-4033.
How LGD-3033 Works
LGD-3033 works by selectively binding to androgen receptors in the body, primarily targeting muscle and bone tissues. This selective action stimulates anabolic activity, leading to increased muscle mass, improved bone density, and enhanced physical performance without the side effects typically associated with traditional anabolic steroids. By promoting the regeneration of muscle fibers and strengthening skeletal structures, LGD-3033 supports overall musculoskeletal health. Additionally, its effects on androgen receptors may improve sexual function and contribute to a reduction in urinary tract infections by supporting tissue integrity and immune responses in the urinary system.
Chemical Structure of LGD-3033
Research on LGD-3033
A. May Help Maintain Bone Strength and Quality
LGD-3033 maintains bone strength and quality by selectively binding to androgen receptors in bone tissue, stimulating anabolic processes that promote bone formation and mineral density. This activation enhances osteoblast activity (cells responsible for bone formation) while reducing osteoclast activity (cells that break down bone), leading to stronger and denser bones. By preserving bone mass and improving structural integrity, LGD-3033 may help prevent bone loss and reduce the risk of fractures, making it a potential therapeutic option for conditions like osteoporosis.
- In female rats, combination therapy with LGD-3033 and alendronate may be helpful in treating osteoporosis. [1]
- In men and women, SARMs were shown to have beneficial effects on osteoporosis. [2]
- A study showed that SARMs can both prevent bone loss and stimulate bone formation. [3]
- In patients with osteoporosis, SARMs such as LGD-3033 increased bone mineral density (BMD). [4]
- In preclinical models, LGD-3033 increased BMD and bone strength at various skeletal sites. [5]
- In rats, the administration of LGD-3033 promoted bone growth and prevented bone breakdown. [6-9]
- In animal models, LGD-3033 accelerated the healing of bone injuries. [10]
B. May Improve Sexual Function
LGD-3033 improves sexual function by selectively activating androgen receptors involved in regulating sexual health and reproductive tissues. This activation can enhance libido, increase sexual stamina, and improve overall sexual performance by supporting hormone balance and tissue health. By targeting androgen receptors without affecting other hormonal pathways, LGD-3033 may boost blood flow to sexual organs, improve sensitivity, and promote the maintenance of healthy sexual function. Its anabolic effects also contribute to better physical energy and endurance, which can further enhance sexual well-being.
- In female rats, it was shown that LGD-3033 can stimulate female sexual behavior. [11]
- A study showed that SARMs increased sexual motivation in rats who had surgical removal of the ovaries. [12]
- In women, LGD-3033 enhanced libido and other parameters of sexuality. [13]
- In rats, LGD-3033 enhanced sexual preference of females for males. [14]
- In female rats who had surgical removal of the ovaries, LGD-3033 increased sexual motivation. [15]
- In female rats, LGD-3033 administration stimulated sexual behavior. [16]
- In male rats, LGD-3033 and other SARMs improved mounts, intromissions, ejaculations, and copulation efficiency. [17]
- In castrated rodent models, LGD-3033 appears to maintain male reproductive behavior. [18]
C. May Help Improve Muscle Mass and Strength
LGD-3033 may help improve muscle mass and strength by selectively activating androgen receptors in muscle tissue, stimulating anabolic (muscle-building) processes. This activation enhances protein synthesis, which is essential for muscle growth and repair. By increasing nitrogen retention and muscle fiber regeneration, LGD-3033 supports the development of lean muscle mass and improves overall physical performance. Its targeted action on muscle receptors allows for these benefits without the severe side effects associated with traditional anabolic steroids, making it a promising option for improving strength and muscle density.
- In rats, LGD-3033 was associated with increased muscle activity. [19]
- In female rats, LGD-3033 administration resulted in increased muscle weight. [20]
- In cancer patients with muscle wasting, LGD-3033 consistently increased lean body mass and improved physical function and quality of life. [21]
- In healthy men, LGD-3033 increased lean muscle mass and improved functional measures. [22]
- In patients with muscle wasting, LGD-3033 increased lean muscle mass without any adverse side effects. [23]
- In cancer patients with muscle wasting, LGD-3033 improved muscle mass and strength, thereby allowing the subjects to undergo more intensive treatments such as radiation and chemotherapy. [24]
D. May Decrease Urinary Tract Infections
LGD-3033 may decrease urinary tract infections (UTIs) by enhancing tissue integrity and supporting the health of the urinary tract lining. Its selective activation of androgen receptors can strengthen the pelvic floor muscles, which play a role in maintaining bladder control and reducing residual urineāa common risk factor for UTIs. Additionally, improved immune response and tissue repair from androgen receptor stimulation may create a more resilient barrier against bacterial invasion, lowering the likelihood of infection.
- In rats, it was shown that SARMs were effective in treating stress urinary incontinence (SUI). [25]
- In mice who had surgical removal of the ovaries, SARMs decreased symptoms associated with stress urinary incontinence (SUI). [26]
LGD 3033 Half Life
LGD-3033 Half-Life Overview
LGD-3033 is a selective androgen receptor modulator (SARM) known for its potential muscle-building and fat-loss properties. Although research on LGD-3033 is limited, preliminary reports suggest it has a relatively short half-life compared to other SARMs. This means the compound is metabolized and eliminated from the body more quickly, affecting how frequently it needs to be dosed.
Estimated Half-Life of LGD-3033
While exact clinical data is lacking, anecdotal evidence and user reports estimate the half-life of LGD-3033 to be approximately 6 to 12 hours. This short half-life suggests that users may need to take multiple doses throughout the day to maintain stable blood levels and maximize its effects. Regular dosing is believed to help sustain muscle growth, strength gains, and other potential benefits.
Implications of LGD-3033ās Half-Life
Due to its short half-life, consistent and careful dosing is crucial for those using LGD-3033. Missing a dose could lead to fluctuating hormone levels, reducing its efficacy. Additionally, the rapid metabolism may lead to faster clearance from the body, which could be relevant for individuals concerned about detection in drug tests. As research on LGD-3033 continues, more precise information on its pharmacokinetics may become available.
LGD 3033 Side Effects
LGD-3033 Side Effects Overview
LGD-3033 is a selective androgen receptor modulator (SARM) known for its potential to enhance muscle growth and improve bone density. While research on LGD-3033 is still limited, users have reported various side effects similar to other SARMs. These side effects may vary depending on dosage, duration of use, and individual sensitivity.
Common Side Effects
Some of the most frequently reported side effects of LGD-3033 include hormonal imbalances such as suppressed testosterone levels, which can lead to fatigue, decreased libido, and mood swings. Users may also experience mild headaches, nausea, and joint pain. Water retention and increased blood pressure have been observed in some cases, especially with prolonged use or higher doses.
Long-Term Risks and Considerations
Long-term use of LGD-3033 may increase the risk of more serious side effects, such as liver toxicity and cardiovascular issues. Post-cycle therapy (PCT) is often recommended after using LGD-3033 to restore natural hormone levels and reduce the risk of lasting endocrine disruption.
LGD 3033 vs 4033
LGD-3033 and LGD-4033 are both selective androgen receptor modulators (SARMs) known for their muscle-building and performance-enhancing properties. LGD-4033, also known as Ligandrol, is the more widely researched and commonly used of the two. It is known for promoting lean muscle gains, improving strength, and aiding in recovery without the severe side effects associated with anabolic steroids. LGD-3033 is a newer SARM with less research but is believed to have similar anabolic effects with a shorter half-life, meaning it may clear from the system more quickly.
The primary difference between LGD-3033 and LGD-4033 lies in their potency and duration of action. LGD-4033 is considered more potent and has a longer half-life of approximately 24ā36 hours, allowing for once-daily dosing. LGD-3033, on the other hand, has a shorter half-life, which may require multiple doses per day to maintain stable blood levels. While both SARMs target androgen receptors to enhance muscle growth, LGD-4033 is better studied for safety and efficacy, while LGD-3033 is still under investigation for its full range of effects.
When comparing LGD-3033 and LGD-4033, users should consider factors such as research backing, side effects, and personal goals. LGD-4033 has more clinical data supporting its effectiveness and safety profile, making it a more reliable choice for those seeking significant muscle gains. LGD-3033 may offer faster results due to its shorter action window but could require more frequent dosing. Both compounds may suppress natural testosterone levels, requiring post-cycle therapy (PCT) to restore hormonal balance. As with any performance-enhancing substance, caution and adherence to safe usage guidelines are essential.
LGD 3033 Dosage
LGD-3033 is a selective androgen receptor modulator (SARM) known for its potential to enhance muscle growth, strength, and fat loss. While research on LGD-3033 is still limited, anecdotal reports suggest that dosages typically range from 5 mg to 20 mg per day. Users often start with a lower dose to assess tolerance before gradually increasing it.
For beginners, a dosage of 5-10 mg daily is common to minimize potential side effects while promoting lean muscle gains. Intermediate users seeking more pronounced effects may increase the dosage to 15-20 mg per day. It is usually taken in a 6 to 8-week cycle, with some users splitting the daily dose into two administrations for more stable blood levels.
Due to its impact on hormone levels, post-cycle therapy (PCT) is recommended after completing an LGD-3033 cycle to restore natural testosterone production. Common PCT protocols may include selective estrogen receptor modulators (SERMs) like nolvadex or clomid for 4-6 weeks. Monitoring for side effects such as testosterone suppression, fatigue, or mood changes is essential during and after the cycle.
LGD 3033 Injectable
LGD-3033 is a selective androgen receptor modulator (SARM) known for its potential to promote muscle growth, increase strength, and improve bone density. It is a newer compound in the SARM family and is being studied for its anabolic properties while minimizing androgenic side effects. The injectable form is considered by some users to offer better bioavailability and faster absorption compared to oral administration, potentially enhancing its efficacy.
Users of LGD-3033 injectable report increased lean muscle mass, improved recovery times, and enhanced physical endurance. It is believed to work by selectively binding to androgen receptors in muscle and bone tissues, stimulating anabolic activity without the extensive side effects associated with traditional anabolic steroids. This makes it attractive for athletes and bodybuilders seeking performance enhancement while aiming to avoid hormonal imbalances.
LGD 3033 vs RAD 140
LGD-3033 and RAD-140 are both selective androgen receptor modulators (SARMs) known for their muscle-building properties. RAD-140 is generally considered more potent, promoting significant muscle mass and strength gains. LGD-3033, while effective, is often seen as a milder option with a lower risk of side effects, making it appealing to beginners or those seeking gradual progress.
RAD-140ās higher potency may lead to more pronounced side effects, including testosterone suppression, mood swings, and potential hair loss. LGD-3033, on the other hand, typically causes fewer hormonal imbalances and is believed to have a safer profile. However, both compounds can suppress natural testosterone levels, requiring post-cycle therapy (PCT) to restore hormonal balance.
RAD-140 is favored by bodybuilders and athletes seeking rapid muscle growth, increased strength, and enhanced endurance. LGD-3033 is often chosen for lean muscle retention during cutting cycles or for users prioritizing fewer side effects. The choice between the two depends on individual goalsāRAD-140 for aggressive gains and LGD-3033 for a balanced, safer approach.
What Does LGD 3033 Do?
LGD-3033 is a selective androgen receptor modulator (SARM) that is believed to target androgen receptors in muscle and bone tissues. It is designed to promote muscle growth, increase strength, and enhance physical performance while minimizing the side effects typically associated with anabolic steroids. Although research on LGD-3033 is still limited, it is often compared to other SARMs like LGD-4033 due to its potential anabolic properties.
Preliminary studies and user reports suggest that LGD-3033 may support lean muscle mass development, improve bone density, and aid in fat loss. It is thought to increase endurance and recovery time, making it popular among athletes and bodybuilders. Additionally, its selective action on androgen receptors may reduce the risk of side effects like hair loss or prostate enlargement associated with traditional anabolic steroids.
FAQ
What are the results of LGD-3303?
LGD-3303 is reported to increase lean muscle mass, enhance strength, and improve bone density. It may also accelerate fat loss while preserving muscle, largely due to increased muscle protein synthesis, making it appealing for both bulking and cutting cycles. Users often experience faster recovery and improved physical performance. However, LGD-3303 may suppress luteinizing hormone, which is responsible for stimulating natural testosterone production. This suppression of luteinizing hormone can lead to hormonal imbalances, making post-cycle therapy (PCT) necessary to restore normal hormone levels. Like other SARMs, LGD-3303 may cause adverse effects, including fatigue, mood changes, and temporary decreases in libido. It is essential to monitor for adverse effects and follow proper dosing protocols to minimize health risks.
What does LGD do to testosterone?
LGD compounds, including LGD-3303 and LGD-4033, specifically target androgen receptors and can suppress natural testosterone production by interfering with the bodyās hormonal feedback loop. This suppression occurs because LGD affects the regulation of sex hormones, disrupting the body’s natural balance. While these compounds are known for increasing muscle size, the degree of suppression varies depending on dosage and duration of use. Prolonged exposure can further impact sex hormones, leading to hormonal imbalances, even as users seek to enhance muscle size and physical performance.
What is the function of LGD-3303?
The primary function of LGD-3303 is to act as a selective androgen receptor modulator (SARM) that specifically targets androgen receptors, promoting anabolic activity in muscle and bone tissues while minimizing androgenic effects. It interacts with androgen receptors in the human body, enhancing muscle growth and bone density. It is being researched for potential therapeutic use in conditions like osteoporosis and muscle wasting, aiming to improve overall physical function in the human body.
What is the half-life of LGD?
LGD-4033 has a half-life of approximately 24-36 hours, requiring once-daily dosing. The half-life of LGD-3303 is estimated to be shorter, around 6-12 hours, leading to the need for multiple doses per day for stable blood levels. Both compounds are believed to enhance protein synthesis, contributing to increased muscle growth and faster recovery. These effects make them popular among individuals seeking to improve athletic performance through increased strength and endurance. By promoting faster muscle repair, LGD compounds may also support athletic performance during intense training cycles.
What are the results of LGD 3303?
LGD-3303 typically results in increased muscle mass, enhanced strength, better endurance, and improved bone density. Users also report faster recovery times and reduced body fat when combined with a healthy diet and training. This compound may enhance metabolic activity, promoting more efficient energy use and fat loss. In some cases, the use of exogenous testosterone may be necessary to counteract hormone suppression caused by LGD-3303. Maintaining a healthy diet alongside supplementation can further support muscle growth, metabolic activity, and overall well-being.
How do you feel on LGD?
Users commonly report feeling stronger, more energized, and experiencing faster recovery while on LGD compounds. The anabolic and androgenic effects of these compounds may also contribute to increased muscle mass and improved physical performance. Some also describe improved focus and stamina, along with increased bone density, though side effects like fatigue, mood swings, or mild suppression may occur. Additionally, the anabolic and androgenic effects can enhance muscle retention during cutting phases, supporting overall body composition improvements.
What does LGD 3303 do?
LGD-3303 selectively targets androgen receptors to promote muscle growth and bone density without the severe side effects of anabolic steroids. It is designed to enhance physical performance while reducing muscle wasting in medical contexts. For individuals pursuing fitness goals, LGD-3303 is often considered for its ability to support muscle gains and improve strength. However, the World Anti-Doping Agency classifies SARMs, including LGD-3303, as prohibited substances due to their performance-enhancing effects. Athletes subject to testing by the World Anti-Doping Agency should avoid using LGD-3303 to comply with anti-doping regulations and consider alternative methods to achieve their fitness goals.
Are SARMs toxic to the liver?
Yes, SARMs like LGD-3303 and LGD-4033 can be hepatotoxic, especially when used at high doses or for prolonged periods. These compounds are often studied for research purposes, as they work by targeting specific androgen receptors, which can influence various tissues in the body. Although generally less toxic than traditional steroids, they can still strain liver function and elevate liver enzymes, particularly in individuals with higher body weight. The selective action on specific androgen receptors is believed to reduce some side effects, but liver stress remains a concern with prolonged use. For research purposes, it is crucial to monitor liver health and understand the potential risks associated with these compounds.
Does LGD lower testosterone?
Yes, LGD compounds can lower natural testosterone production through negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis. For research purposes, this suppression is being studied to understand its long-term effects on hormone regulation. This suppression may also affect lipid profiles, potentially lowering good cholesterol (HDL) levels and contributing to water retention in some users. Post-cycle therapy (PCT) is often recommended to restore hormonal balance, reduce water retention, and support the recovery of good cholesterol levels and overall health. Further investigations for research purposes continue to explore how LGD compounds impact endocrine and metabolic functions.
What are the health benefits of LGD 4033?
LGD-4033 is being researched for its potential to treat muscle wasting, osteoporosis, and age-related muscle loss. In performance contexts, it may increase muscle mass, improve strength, and enhance physical recovery. For research purposes, some studies also suggest it could have an impact on the cardiovascular system, although more research is needed to understand its long-term effects. Like most SARMs, it is believed to offer anabolic benefits with fewer androgenic side effects compared to traditional steroids. Users should consult a healthcare professional to better understand the risks and benefits associated with LGD-4033 use. Additionally, a healthcare professional can provide guidance on monitoring potential side effects, particularly regarding muscle growth and the cardiovascular system, when considering its use for research purposes.
Is RAD140 hard on the liver?
Yes, RAD140 (Testolone) can be hard on the liver, especially at high doses. It may elevate liver enzyme levels, indicating stress on the liver, though it is considered less hepatotoxic than anabolic steroids. Some research also suggests it may impact fat cells, potentially influencing body composition and affecting bad cholesterol levels.
Does RAD140 cause gynecomastia?
While RAD140 does not convert directly to estrogen, hormonal imbalances caused by testosterone suppression could lead to gynecomastia (enlargement of male breast tissue) in some users. This occurs because RAD140 interacts with certain receptors that influence hormone regulation. Using a PCT supplement after a RAD140 cycle may help restore natural testosterone levels and reduce the risk of estrogen-related side effects. Ligand Pharmaceuticals, the company associated with the development of RAD140, has focused on advancing selective androgen receptor modulators (SARMs) for medical use. Although RAD140 shows promise, ongoing research by Ligand Pharmaceuticals aims to better understand its long-term effects and safety profile. By targeting certain receptors, RAD140 seeks to deliver anabolic benefits while minimizing androgenic side effects. Incorporating a PCT supplement is often recommended to support hormonal recovery and maintain the gains achieved during the cycle.
Does RAD140 decrease testosterone?
Yes, both LGD-3303 and LGD-4033 have shown potential to increase bone density by stimulating androgen receptors in bone tissue, making them candidates for treating osteoporosis and bone-related conditions. Some sports organizations closely monitor the use of SARMs due to their performance-enhancing properties and potential health risks. Some users also report changes in blood pressure, which may require monitoring during use. Additionally, blood pressure fluctuations could be linked to the compoundās effects on hormone levels and fluid retention, raising concerns for athletes regulated by sports organizations.
What does LGD-3303 do?
LGD-3303 enhances muscle growth, improves bone density, and increases strength by selectively binding to androgen receptors. It is considered a promising compound for both medical and performance applications, particularly in areas related to bone health and sex drive. Research suggests it may help improve bone health by increasing bone density and supporting overall skeletal strength. Some studies indicate that administering three doses per day may help maintain stable blood levels and optimize its effects. Additionally, users report that splitting three doses throughout the day could enhance absorption, improve sex drive, and boost overall performance outcomes.
Reference
Vajda EG, Hogue A, Griffiths KN, Chang WY, Burnett K, Chen Y, Marschke K, Mais DE, Pedram B, Shen Y, van Oeveren A, Zhi L, LĆ³pez FJ, Meglasson MD. Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats. J Bone Miner Res. 2009 Feb;24(2):231-40. doi: 10.1359/jbmr.081007. PMID: 18847323.
Narayanan R, Mohler ML, Bohl CE, Miller DD, Dalton JT. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal. 2008;6:e010. doi:10.1621/nrs.06010.
Rosen J, Negro-Vilar A. Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile. J Musculoskelet Neuronal Interact. 2002 Mar;2(3):222-4. PMID: 15758439.
Cilotti A, Falchetti A. Male osteoporosis and androgenic therapy: from testosterone to SARMs. Clinical Cases in Mineral and Bone Metabolism. 2009;6(3):229-233.
Miner JN, Chang W, Chapman MS, et al. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology.
Kearbey JD, Gao W, Fisher SJ, Wu D, Miller DD, Dalton JT. Effects of selective androgen receptor modulator (SARM) treatment in osteopenic female rats. Pharmaceutical research. 2009; 26(11):2471-7.
Gao W, Reiser PJ, Coss CC, Phelps MA, Kearbey JD, Miller DD, Dalton JT. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology. 2005;146:4887ā4897.
Gao W, Reiser PJ, Kearbey JD, Phelps MA, Coss CC, Miller DD, Dalton JT. Effects of Novel Selective Androgen Receptor Modulator (SARM) on Skeletal Muscle Mass and Strength in Castrated Male Rats. The Endocrine Society; New Orleans: 2004.
Kearbey JD, Gao W, Narayanan R, Fisher SJ, Wu D, Miller DD, Dalton JT. Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharmaceutical research. 2007;24:328ā335.
Seeman E. Periosteal bone formation–a neglected determinant of bone strength. The New England journal of medicine. 2003; 349(4):320-3.
Kudwa AE, LĆ³pez FJ, McGivern RF, Handa RJ. A selective androgen receptor modulator enhances male-directed sexual preference, proceptive behavior, and lordosis behavior in sexually experienced, but not sexually naive, female rats. Endocrinology. 2010 Jun;151(6):2659-68. doi: 10.1210/en.2009-1289. Epub 2010 Apr 14. PMID: 20392832.
Negro-Vilar A. Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. The Journal of clinical endocrinology and metabolism. 1999; 84(10):3459-62.
Kudwa AE, LĆ³pez FJ, McGivern RF, Handa RJ. A selective androgen receptor modulator enhances male-directed sexual preference, proceptive behavior, and lordosis behavior in sexually experienced, but not sexually naive, female rats. Endocrinology. 2010; 151(6):2659-68. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/20392832.
Jones A, Hwang DJ, Duke CB. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation. The Journal of pharmacology and experimental therapeutics. 2010; 334(2):439-48.
Retrieved from https://academic.oup.com/endo/article/151/6/2659/2456825.
Miner JN, Chang W, Chapman MS. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology. 2007; 148(1):363-73. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/17023534.
Miner JN, Chang W, Chapman MS, Finn PD, Hong MH, Lopez FJ, Marschke KB, Rosen J, Schrader W, Turner R, van Oeveren A, Viveros H, Zhi L, Negro-Vilar A. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology. 2007;148:363ā373.
Jones A, Hwang DJ, Duke CB 3rd, He Y, Siddam A, Miller DD, Dalton JT. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation. J Pharmacol Exp Ther. 2010 Aug;334(2):439-48. doi: 10.1124/jpet.110.168880. Epub 2010 May 5. PMID: 20444881; PMCID: PMC2913771.
Vajda EG, LĆ³pez FJ, Rix P, Hill R, Chen Y, Lee KJ, O’Brien Z, Chang WY, Meglasson MD, Lee YH. Pharmacokinetics and pharmacodynamics of LGD-3033[9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator. J Pharmacol Exp Ther. 2009 Feb;328(2):663-70. doi: 10.1124/jpet.108.146811. Epub 2008 Nov 18. PMID: 19017848.
Vajda EG, Hogue A, Griffiths KN, Chang WY, Burnett K, Chen Y, Marschke K, Mais DE, Pedram B, Shen Y, van Oeveren A, Zhi L, LĆ³pez FJ, Meglasson MD. Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats. J Bone Miner Res. 2009 Feb;24(2):231-40. doi: 10.1359/jbmr.081007. PMID: 18847323.
Dalton JT, Taylor RP, Mohler ML, Steiner MS. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer. Current opinion in supportive and palliative care. 2013; 7(4):345-51.
Retrievedfrom http://www.biotechduediligence.com/uploads/6/3/6/7/6367956/lgnd_sarm_poster.pdf
Chekler E. L.. Tissue selective androgen receptor modulators (SARMs): A path to a clinical candidate. Abstracts of Papers, 250th ACS National Meeting & Exposition, Boston, MA, United States, August 16ā20, 2015; MEDI-345.
Narayanan R, Mohler ML, Bohl CE, Miller DD, Dalton JT. Selective androgen receptor modulators in preclinical and clinical development. Nuclear Receptor Signaling. 2008;6:e010. doi:10.1621/nrs.06010.
Kadekawa K, Kawamorita N, Shimizu T, Kurobe M, Turnbull PS, Chandra S, Kambara T, Barton JC, Russell AJ, Yoshimura N. Effects of a selective androgen receptor modulator (SARM), GSK2849466A, on stress urinary incontinence and bladder activity in rats with ovariectomy-induced oestrogen deficiency. BJU Int. 2020 Jun;125(6):911-919. doi: 10.1111/bju.15022. Epub 2020 Mar 20. PMID: 32011085; PMCID: PMC7261644.
Miller CP, Shomali M, Lyttle CR, et al. Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140. ACS Medicinal Chemistry Letters. 2011;2(2):124-129. doi:10.1021/ml1002508. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018048/.
Success Stories
before after
At the age of 60, I look and feel better than I ever have in my entire life! Switching my health program and hormone replacement therapy regimen over to Genemedics was one of the best decisions Iāve ever made in my life! Genemedics and Dr George have significantly improved my quality of life and also dramatically improved my overall health. I hav...
Nick Cassavetes ,60 yrs old
Movie Director (āThe Notebookā, āJohn Qā, āAlpha Dogā), Actor and Writer
Call 800-277-4041 for a Free Consultation
- Usually takes 15-30 minutes
- Completely confidential
- No obligation to purchase anything
- We will discuss your symptoms along with your health and fitness goals
- Free post-consult access for any additional questions you may have
© Copyright Genemedics Health Institute. All Rights Reserved. Privacy Policy.